Recro Pharma, Inc. - stock spinoff
Stock symbol REPH is outdated, potentially delisted? Maybe it is available on other exchange?
Stock spin-offs
Date | Child company | Number of Shares |
---|---|---|
2019-11-22 | BXRX | 0.400 |
REPH
Price: $2.09
52 week price:
Earnings Per Share: -0.29 USD
P/E Ratio: -0.81
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 177438
Ebitda: -8.8 millionMarket Capitalization: 79.2 million